To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Motivational Interviewing Based on the COM-B Model
NCT ID:
NCT06509529
Condition:
Cervical Cancer
Conditions: Official terms:
Uterine Cervical Neoplasms
Conditions: Keywords:
Cervical Cancer
Motivational Interviewing
Early Diagnosis and Screening
Health Beliefs
Nursing
COM-B Model
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Other
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
Motivational Interviewing Based on the COM-B Model
Description:
Motivational Interviewing Based on the COM-B Model will be applied to the women in the
experimental group.
Arm group label:
Experimental group
Summary:
This research will be conducted to determine the effect of motivational interviewing
based on the COM-B model on women's cervical cancer health beliefs and participation in
screening.
Detailed description:
Cancer is an important public health problem in terms of mortality and morbidity in the
world and in our country, and ranks second among the causes of death. It can reduce the
mortality and morbidity rate in cancer with early diagnosis and screening studies. One of
the cancers for which early diagnosis and screening studies are carried out in women is
cervical cancer, and it is the 4th most frequently diagnosed cancer type that causes
death in women. Although early diagnosis and screening studies are carried out, women do
not participate in enough cervical cancer screenings for different reasons. Interventions
are needed to increase women's motivation to participate in screening. This research will
be conducted to determine the effect of motivational interviewing based on the COM-B
model on women's cervical cancer health beliefs and participation in screening. The
research is planned as a parallel group single-blind randomized controlled experimental
study and will be conducted on women between the ages of 30-65 who are registered at
Altınordu Central Family Health Center in Ordu Province. The population of the research
will be women between the ages of 30-65 who are registered at Altınordu Central Family
Health Center, and the sample will be 74 women who meet the research criteria and agree
to participate in the research. The data of the research will be collected with the
"Information Form", "Cervical Cancer and Pap Smear Test Health Belief Model Scale",
"Cervical Cancer Screening Status Evaluation Form" and "Satisfaction Evaluation Form". A
motivational interview program based on the COM-B Model will be applied to the women in
the experimental group for 1 month (1st week face-to-face, 2nd, 3rd and 4th weeks
online). No intervention will be applied to the control group during the research
process. The analysis of the data will be done in a computer environment by an expert
statistician. Necessary institutional permissions and ethics committee approval will be
obtained for the research.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Registered at Altınordu Central Family Health Center,
- A woman,
- Between 30-65 years of age,
- The one who is married,
- Have not had a Pap Smear test in the last 5 years,
- Has a smart phone
- Has an internet connection,
- Open to communication and collaboration,
- Women who volunteer to participate in the study will be included in the study.
Exclusion Criteria:
- Who had total hysterectomy surgery,
- The pregnant one,
- Those diagnosed with cervical cancer and
- Women with a psychiatric diagnosis will be excluded from the study.
Gender:
Female
Gender based:
Yes
Minimum age:
30 Years
Maximum age:
65 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
August 15, 2024
Completion date:
January 30, 2025
Lead sponsor:
Agency:
T.C. ORDU ÜNİVERSİTESİ
Agency class:
Other
Source:
T.C. ORDU ÜNİVERSİTESİ
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06509529
